Mounjaro®
Starting from £179.99/mo
Start journey Learn moreIf 2.5mg tirzepatide feels like it isn't doing anything, you're not imagining it — and you're not failing the treatment. The 2.5mg starting dose exists for one reason only: to let your body adjust to the medicine before therapeutic doses begin. Weight loss at this stage is not the goal. Most people spend four weeks here, notice little change on the scales, and wonder whether Mounjaro is working at all. That's a completely normal and medically expected experience. These are prescription-only medicines, and a GPhC-registered prescriber decides when and how your dose progresses based on your individual clinical picture.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Picture this: you've taken your first two or three injections, you've been watching what you eat, and the scales haven't moved. You start quietly wondering whether you were given the wrong pen, or whether tirzepatide simply doesn't work for you. A question our prescribers hear most weeks, in almost those exact words.
Here's the honest answer. The 2.5mg pen isn't designed to produce weight loss. Its job is adjustment, settling your digestive system into the presence of a dual GIP and GLP-1 receptor agonist before the dose climbs to levels that genuinely suppress appetite and slow gastric emptying. Think of those four weeks as the body's calibration period. The medicine is biologically active; your appetite suppression signals are starting to change. The scales just aren't where the action is yet.
The NHS tirzepatide patient information page describes the standard titration pathway, which begins at 2.5mg before progressing through higher doses. Weight loss, when it comes, builds gradually across months, not in the first pen. If you want a closer look at what the 5mg dose phase typically looks like compared to this one, the Mounjaro 5mg overview walks through what changes once titration begins.
Tirzepatide works through two receptor pathways (GIP and GLP-1) affecting appetite signalling, gastric motility and metabolic rate. Those changes don't produce instant, visible results. In SURMOUNT-1, participants who eventually lost around 20% of their body weight did so across 72 weeks of treatment, starting at exactly the same 2.5mg pen you're holding now. The early weeks contribute to that outcome; they just don't announce themselves on the bathroom scales.
What you might notice at 2.5mg: mild nausea, some fatigue, a slightly fuller feeling after smaller meals, occasional digestive changes. Those aren't side effects to push through while nothing happens, they're signals that the medicine is engaging the receptors it's supposed to engage. The appetite shift tends to become more noticeable as the dose increases, but the groundwork is being laid from day one.
If you're finding the early side effects difficult or have questions about what's normal, our general FAQs cover the most common experiences people have in the first weeks. And if you're already thinking ahead to what happens if things still feel slow once you reach 5mg, there's a dedicated page on tirzepatide 5mg not working that addresses that scenario directly.
Titration timing is a clinical decision, not a personal one. The standard approach, as described in the Mounjaro SmPC, involves staying at each dose for roughly four weeks before the prescriber considers moving up. That's a minimum, not a guarantee, your prescriber weighs how well you're tolerating the current dose, any relevant health information, and what your body is doing overall.
At a regulated service like ours, every repeat order goes through a fresh clinical review before anything is dispensed. A real prescriber reads your update; dose progression isn't automatic. This matters because moving up too fast is a common reason people abandon treatment due to side effects, while staying at 2.5mg indefinitely means staying at a dose that was never intended to produce the results you're looking for.
If you're approaching the end of your first four weeks and want to understand what the repeat process looks like, the Mounjaro pillar page covers the full treatment arc from eligibility through to ongoing management. For context on what private treatment typically costs once you move into the therapeutic doses, our Mounjaro cost overview explains what to expect and what a legitimate price actually includes.
Four weeks at 2.5mg with no weight change is expected. Four weeks at a therapeutic maintenance dose with no change at all is a different conversation. If you've been titrated appropriately and still feel nothing is moving after several months at higher doses, that's worth raising with your prescriber rather than quietly stopping treatment, and our page on what to do when 5mg Mounjaro doesn't seem to be working is a useful starting point before that conversation.
A few things that genuinely do affect how well tirzepatide works at any dose: calorie intake (appetite suppression helps, but doesn't eliminate dietary choices entirely), sleep quality, medications that can affect weight independently, and underlying conditions such as hypothyroidism that may need separate management.
For patients who are still on the 2.5mg pen and specifically wondering about the Mounjaro formulation rather than tirzepatide generally, the 2.5mg Mounjaro not working page covers the same ground with brand-specific framing. And if you're thinking about whether this treatment is the right fit at all, our weight loss treatment overview sets out the options clearly. Starting a conversation with our prescribers costs nothing, your free consultation is the place to do that.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.